SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD. Financials Shanghai MicroPort MedBot (Group) Co., Ltd.
Equities
2252
CNE100004QP1
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16 HKD | +1.01% |
|
+1.91% | -23.26% |
| 05-10 | EU Grants CE Mark to Shanghai Medbot's Laparoscopic Surgical Robot | MT |
| 03-27 | Shanghai MicroPort MedBot Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 45,732 | 26,922 | 18,166 | 14,183 | - | - |
| Enterprise Value (EV) 1 | 43,996 | 26,394 | 18,166 | 14,477 | 14,975 | 15,184 |
| P/E ratio | -75.7 x | -23.6 x | -17.9 x | -21.8 x | -31.4 x | -358 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 21,271 x | 1,246 x | 174 x | 63.1 x | 20.3 x | 10.1 x |
| EV / Revenue | 20,463 x | 1,222 x | 174 x | 64.4 x | 21.5 x | 10.8 x |
| EV / EBITDA | -85.2 x | -26.5 x | -21 x | -24.5 x | -36.4 x | 155 x |
| EV / FCF | -65.5 x | -24.3 x | - | -17 x | -22.2 x | - |
| FCF Yield | -1.53% | -4.12% | - | -5.87% | -4.5% | - |
| Price to Book | 19.1 x | 19 x | - | 1,127 x | 55.8 x | 66 x |
| Nbr of stocks (in thousands) | 958,594 | 958,594 | 958,594 | 958,594 | - | - |
| Reference price 2 | 47.71 | 28.09 | 18.95 | 14.80 | 14.80 | 14.80 |
| Announcement Date | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 2.15 | 21.6 | 104.6 | 224.9 | 697.2 | 1,403 |
| EBITDA 1 | - | -516.3 | -994.6 | -863.4 | -590.7 | -411.7 | 97.97 |
| EBIT 1 | - | -551.7 | -1,095 | -975.1 | -637 | -434 | 17.88 |
| Operating Margin | - | -25,660.23% | -5,069.96% | -932.32% | -283.22% | -62.25% | 1.28% |
| Earnings before Tax (EBT) 1 | - | -584.5 | -1,146 | -1,024 | -694 | -519 | -99 |
| Net income 1 | -208.9 | -582.9 | -1,140 | -1,012 | -686 | -513.1 | -98 |
| Net margin | - | -27,112.6% | -5,276.15% | -967.74% | -305.02% | -73.6% | -6.99% |
| EPS 2 | -0.2700 | -0.6300 | -1.190 | -1.060 | -0.6782 | -0.4704 | -0.0413 |
| Free Cash Flow 1 | - | -671.5 | -1,087 | - | -850 | -674 | - |
| FCF margin | - | -31,231.72% | -5,030.53% | - | -377.94% | -96.68% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 21/10/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 295 | 793 | 1,001 |
| Net Cash position 1 | - | 1,736 | 528 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.4992 x | -1.925 x | 10.22 x |
| Free Cash Flow 1 | - | -671 | -1,087 | - | -850 | -674 | - |
| ROE (net income / shareholders' equity) | - | -30.4% | -59.8% | - | -140% | -44.1% | -7.56% |
| ROA (Net income/ Total Assets) | - | -25.9% | -48.3% | - | -51% | -30.9% | -4% |
| Assets 1 | - | 2,248 | 2,361 | - | 1,345 | 1,660 | 2,450 |
| Book Value Per Share 2 | - | 2.500 | 1.480 | - | 0.0100 | 0.2700 | 0.2200 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | - | 131 | 188 | - | 41.7 | 96.7 | 58.7 |
| Capex / Sales | - | 6,092.84% | 871.5% | - | 18.52% | 13.86% | 4.18% |
| Announcement Date | 21/10/21 | 29/03/22 | 29/03/23 | 27/03/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.8
CNY
Average target price
21.26
CNY
Spread / Average Target
+43.70%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.26% | 1.96B | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- 2252 Stock
- Financials Shanghai MicroPort MedBot (Group) Co., Ltd.
